AbstractWe assessed the effect of CD34+ cell dose on costs in breast cancer patients undergoing autologous peripheral blood stem cell (PBSC) transplantation. Mean hospitalization costs were 26,992.9+/-9582.9 for patients receiving a CD34+ cell dose <5 x 10(6) cells/kg versus 22,339.4+/- 5471.1 for those receiving >5 x 10(6) CD34+ cells/kg (p=0.0065).
Figures & Tables
Vol. 89 No. 9 (2004): September, 2004 : Comparative Studies
Ferrata Storti Foundation, Pavia, Italy
Statistics from Altmetric.com